ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
XTL Biopharmaceuticals Ltd

XTL Biopharmaceuticals Ltd (XTLB)

1,83
0,06
(3,39%)
Beim Schlusskurs: 22 November 10:00PM
1,83
0,00
( 0,00% )
Nach Börsenschluss: 12:56AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
1,83
Gebot
0,885
Fragen
1,88
Volumen
5.765
1,6743 Tagesbereich 1,83
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
1,77
Handelsbeginn
1,715
Letzte Trade
1
@
1.67
Letzter Handelszeitpunkt
22:14:58
Finanzvolumen
US$ 10.278
VWAP
1,7828
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
5.449.061
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-
Nettogewinn
-1,78M

Über XTL Biopharmaceuticals Ltd

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic ... XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Ramat Gan, Center, Isr
Gegründet
-
XTL Biopharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XTLB. The last closing price for XTL Biopharmaceuticals was US$1,77. Over the last year, XTL Biopharmaceuticals shares have traded in a share price range of US$ 0,00 to US$ 0,00.

XTL Biopharmaceuticals currently has 5.449.061 shares in issue. The market capitalisation of XTL Biopharmaceuticals is US$9,64 million.

XTLB Neueste Nachrichten

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement...

XTL Entered Definitive Agreement to Acquire The Social Proxy

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VRPXVirpax Pharmaceuticals Inc
US$ 1,129
(91,45%)
12,45M
MTEMMolecular Templates Inc
US$ 0,5626
(48,05%)
12,58M
EYENEyenovia Inc
US$ 0,1425
(35,59%)
12,54M
BENFBeneficient
US$ 1,07
(21,59%)
1,25M
REPLReplimune Group Inc
US$ 13,01
(17,74%)
301,23k
CETXCemtrex Inc
US$ 0,1424
(-27,61%)
4,03M
KSCPKnightscope Inc
US$ 15,40
(-15,80%)
42,57k
APTOAptose Biosciences Inc
US$ 0,2081
(-14,71%)
271,18k
LGTYLogility Supply Chain Solutions Inc
US$ 9,66
(-13,75%)
26,44k
PROCProcaps Group SA
US$ 0,96
(-13,51%)
533,87k
ELABElevai Labs Inc
US$ 0,02035
(0,74%)
15,74M
MTEMMolecular Templates Inc
US$ 0,5626
(48,05%)
12,58M
EYENEyenovia Inc
US$ 0,1425
(35,59%)
12,54M
VRPXVirpax Pharmaceuticals Inc
US$ 1,129
(91,45%)
12,45M
CDTConduit Pharmaceuticals Inc
US$ 0,1023
(-5,19%)
9,98M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock